Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/532637 stock hub

BOM/532637 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/532637is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

485.8M

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/532637

In the news

Latest news · BOM/532637

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-7.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/532637 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

INR

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	480
Employees Change	48%
Employees Change Percent	11.11
Enterprise value	INR 1.5B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 485.8M
Price	INR 30.69
Price currency	INR
Rev Per Employee	4,950,477.08x
Sic	2834
Symbol	bom/532637
Website	https://www.mangalamdrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-63.65%
EV Earnings	-4.74x
EV/EBITDA	26.99x
EV/Sales	0.62x
P/B ratio	0.38x
P/S ratio	0.2x
PE Ratio10 Y	20.71x
PE Ratio5 Y	25.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.95%
EBITDA Margin	1.42%
Gross margin	37.76%
Gross Profit	INR 897.4M
Gross Profit Growth	-41.49%
Gross Profit Growth Q	-43.38%
Gross Profit Growth3 Y	-13.85%
Gross Profit Growth5 Y	-5.83%
Net Income	INR -309.2M
Pretax Margin	-14.17%
Profit Margin	-13.01%
Profit Per Employee	INR -644,181
Roa5y	5.22
Roe5y	7.41
ROIC	-7.32
Roic5y	8.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-17.96%
Cagr15y	5.39%
Cagr1y	-57.79%
Cagr20y	2.77%
Cagr3y	-35.19%
Cagr5y	-25.51%
Div CAGR10	0%
Revenue Growth	-31.47x
Revenue Growth Q	-34.08x
Revenue Growth3 Y	-16.69x
Revenue Growth5 Y	-8.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 33.8M
Debt	INR 1B
Debt EBITDA	INR 18.67
Debt Equity	INR 0.8
Equity	INR 1.3B
Interest Coverage	-1.23
Net Cash	INR -980.9M
Net Cash By Market Cap	INR -202
Net Debt EBITDA	INR 29.04
Net Debt Equity	INR 0.77
Tangible Book Value	INR 976.5M
Tangible Book Value Per Share	INR 61.68
WACC	8.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%
Dividend per share	INR 0
Last Dividend	INR 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-86.18%
1Y total return	-57.77%
200-day SMA	50.43
3Y total return	-72.78%
50-day SMA	30.08
50-day SMA vs 200-day SMA	50under200
5Y total return	-77.05%
All Time High	441.5
All Time High Change	-93.05%
All Time High Date	2015-12-08
All Time Low	3.43
All Time Low Change	794.75%
All Time Low Date	2014-03-21
ATR	0.91
Beta	0.12
Beta1y	0.47
Beta2y	0.28
Ch YTD	11.24
High	30.69
High52	94.8
High52 Date	2025-07-08
High52ch	-67.63%
Low	30.69
Low52	22.7
Low52 Date	2025-12-29
Low52ch	35.2%
Ma50ch	2.01%
Price vs 200-day SMA	-39.14%
RSI	55.25
RSI Monthly	31.17
RSI Weekly	38.32
Sharpe ratio	-1.54x
Sortino ratio	-1.87
Total Return	-0.08%
Tr YTD	11.24
Tr15y	119.68%
Tr1m	0.62%
Tr1w	0.1%
Tr3m	-13.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -165.1M
Operating margin	-6.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,868,263%
Shares Insiders	26.31%
Shares Out	15,828,248
Shares Qo Q	0.04%
Shares Yo Y	0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,498.75x
Bv Per Share	80.58
Ch10y	-86.22
Ch15y	119.1
Ch1m	0.62
Ch1w	0.1
Ch1y	-57.77
Ch20y	70.03
Ch3m	-13.65
Ch3y	-72.78
Ch5y	-77.05
Ch6m	-51.83
Change	1.99%
Change From Open	0
Close	30.09
Days Gap	1.99
Depreciation Amortization	198,907,500
Dollar Volume	601,830.9
Earnings Date	2026-05-14
EBIT	INR -165.1M
EBITDA	INR 33.8M
EPS	INR -19.53
F Score	0
Fiscal Year End	March
Founded	1,972
Income Tax	INR -27.4M
Is Primary Listing	1
Last Earnings Date	2026-01-15
Last Report Date	2025-12-31
Ma150	40.31
Ma150ch	-23.87%
Ma20	29.57
Ma20ch	3.78%
Next Earnings Date	2026-05-14
Open	30.69
Price Date	2026-05-08
Price EBITDA	INR 14.38
Ptbv Ratio	0.5
Relative Volume	3.57x
Revenue	2,376,229,000x
Tax By Revenue	-1.16x
Tr20y	72.65%
Tr6m	-51.83%
Volume	19,610

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/532637 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/532637 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/532637?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+26.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

BOM/532637 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.3

Neutral momentum band

Price vs 200-day MA

-39.1%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

-1.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/532637

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/532637 stock rating?

bom/532637 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/532637 analysis?

The full report lives at /stocks/bom/532637/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/532637?

The latest report frames bom/532637 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/532637 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.